Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 14, 2016; 22(2): 490-500
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.490
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.490
Figure 1 TrkB-mediated signaling pathways and possible therapeutic targets in cancer.
Schematic representation of TrkB receptor, its main downstream signaling pathways, and possible therapeutic targets. Shc: Src homology 2 domain containing transforming protein; Grb2: Growth factor receptor-bound protein 2; Gab1: Grb2 associated binding protein 1; PI3K: Phosphatidylinositol 3-kinase; PDK1: Phosphoinositide-dependent protein kinase 1; mTOR: Mammalian target of rapamycin; mTORC1: mTOR complex 1; SOS: Son of sevenless; MEK: Mitogen-activated protein kinase (MAPK)/ERK kinase; ERK: Extracellular signal-regulated kinase; PLC: Phospholipase C; PKC: Protein kinase C.
- Citation: Akil H, Perraud A, Jauberteau MO, Mathonnet M. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer. World J Gastroenterol 2016; 22(2): 490-500
- URL: https://www.wjgnet.com/1007-9327/full/v22/i2/490.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i2.490